» Articles » PMID: 22543846

Late-life Depression As a Risk Factor for Mild Cognitive Impairment or Alzheimer's Disease in 30 US Alzheimer's Disease Centers

Overview
Publisher Sage Publications
Specialties Geriatrics
Neurology
Date 2012 May 1
PMID 22543846
Citations 84
Authors
Affiliations
Soon will be listed here.
Abstract

Identification of potentially modifiable risk factors for cognitive deterioration is important. We conducted a prospective study of 5,607 subjects with normal cognition and 2,500 subjects with mild cognitive impairment (MCI) at 30 Alzheimer's Disease Centers in the Unites States between 2005 and 2011. Cox regression was used to determine whether depression predicted transition from normal to MCI, or MCI to Alzheimer's disease (AD). Over an average of 3.3 visits, 15% of normal subjects transitioned to MCI (62/1000 per year), while 38% of MCI subjects transitioned to AD (146/1000 per year). At baseline, 22% of participants had recent (within the last two years) depression defined by clinician judgment; 9% and 17% were depressed using the Geriatric Depression Scale (GDS score ≥5) and the Neuropsychiatric Inventory Questionnaire (NPI-Q), respectively. At baseline, depressed subjects performed significantly worse on cognitive tests. Those always depressed throughout follow-up had an increased risk for progression from normal to MCI (RR = 2.35; 95% CI 1.93-3.08) versus never depressed. Normal subjects, identified as depressed at first visit but subsequently improved, were found to have lower risk of progression (RR 1.40 (1.01-1.95)). The 'always depressed' had only a modest increased risk of progression from MCI to AD (RR = 1.21 (1.00-1.46). Results were similar using time-dependent variables for depression or when defining depression via the GDS or NPI-Q. We found no effect of earlier depression (>2 years past). The effect of recent depression did not differ by antidepressant treatment, APOE4 allele status, or type of MCI. In conclusion, late-life depression is a strong risk factor for normal subjects progressing to MCI.

Citing Articles

Exploring mitochondrial blood-based and genetic markers in older adults with mild cognitive impairment and remitted major depressive disorder.

Choi J, Beroncal E, Chernega T, Brooks H, Kennedy J, Fisher C Transl Psychiatry. 2024; 14(1):457.

PMID: 39468012 PMC: 11519657. DOI: 10.1038/s41398-024-03155-9.


The characteristics of cognitive and daily living functions of neurocognitive disorders with delusions in elderly Alzheimer's disease.

Kim S, Lee S PeerJ. 2024; 12:e18026.

PMID: 39285920 PMC: 11404475. DOI: 10.7717/peerj.18026.


Rural-Urban mild cognitive impairment comparison in West Michigan through EHR.

Zhang X, Witteveen-Lane M, Skovira C, Dave A, Jones J, McNeely E Alzheimers Dement (N Y). 2024; 10(3):e12495.

PMID: 39135901 PMC: 11317927. DOI: 10.1002/trc2.12495.


Exploring the Role of Social Factors in Cognitive Frailty among South Korean Older Adults.

Ko Y, Choi K Healthcare (Basel). 2024; 12(14).

PMID: 39057536 PMC: 11275848. DOI: 10.3390/healthcare12141394.


Modal Analysis of Cerebrovascular Effects for Digital Health Integration of Neurostimulation Therapies-A Review of Technology Concepts.

Stefanski M, Arora Y, Cheung M, Dutta A Brain Sci. 2024; 14(6).

PMID: 38928591 PMC: 11201600. DOI: 10.3390/brainsci14060591.


References
1.
Lu P, Edland S, Teng E, Tingus K, Petersen R, Cummings J . Donepezil delays progression to AD in MCI subjects with depressive symptoms. Neurology. 2009; 72(24):2115-21. PMC: 2697965. DOI: 10.1212/WNL.0b013e3181aa52d3. View

2.
Aizenstein H, Andreescu C, Edelman K, Cochran J, Price J, Butters M . fMRI correlates of white matter hyperintensities in late-life depression. Am J Psychiatry. 2011; 168(10):1075-82. PMC: 3656408. DOI: 10.1176/appi.ajp.2011.10060853. View

3.
Frazer A . Serotonergic and noradrenergic reuptake inhibitors: prediction of clinical effects from in vitro potencies. J Clin Psychiatry. 2001; 62 Suppl 12:16-23. View

4.
Korczyn A, Halperin I . Depression and dementia. J Neurol Sci. 2009; 283(1-2):139-42. DOI: 10.1016/j.jns.2009.02.346. View

5.
Dotson V, Beydoun M, Zonderman A . Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment. Neurology. 2010; 75(1):27-34. PMC: 2906403. DOI: 10.1212/WNL.0b013e3181e62124. View